당뇨발병변 진료지침 - 대한내과학회

당뇨발병변 진료지침 - 대한내과학회 당뇨발병변 진료지침 - 대한내과학회

17.03.2014 Views

15:155-174. 15. da Silva AF, Desgranges P, Holdsworth J, et al. The management and outcome of critical limb ischemia in diabetic patients: results of a national survey. Diabetic Med 1996;13:726-728. 16. Day MR, Fish SE, Day RD. The use and abuse of wound care materials in the treatment of diabetic ulcerations. Clin Podiatr Med Surg 1998;15:139-150. 17. DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications of insulin-dependent diabetes mellitus. N. Engl. J. Med 1993;329:977-986. 18. Edelman D, Oddone EZ, Matchar DB. Clinical and radiographic findings that lead to intervention in diabetic patients with foot ulcers. Diabetes Care 1996;19(7):755-757. 19. Edelman D, Hough DM, Glazebrook KN, Oddone EZ. Prognostic value of the clinical examination of the diabetic foot ulcer. J Gen Intern Med 1997;12:537-543. 20. Edelson GV. Systematic and nutritional considerations in diabetic wound healing: Clin Podiatr Med Surg 1998;1:41-48. 21. Faglia E, Favales F, Aldeghi A, et al. Adjunctive systemic hyperbaric oxygen therapy in the treatment of severe prevalently ischemic diabetic foot ulcers. Diabetes Care 1996;19:1338-1343. 22. Faglia E, Favales F, Aldeghi A, et al. Change in major amputation rate in a center dedicated to diabetic foot care during the 1980s: prognostic determinants for major amputation. J Diabetes Compl 1998;2:96-102. 23. Gentzkow G, Iwasaki SD, Hersho KS et al. Use of Dermagraft, a cultured human dermis, to treat diabetic foot ulcers. DiabetesCare 1996;19(4):350-354. 24. Giacalone VF, Krych SM, Harkless LB. The University of Texas Health Science Centre at San Antonio: Experience with foot surgery in diabetics. J of Foot and Ankle Surg 1994;33(6):590-597. 25. Hehenberger K, Kratz G, Hansson A, Brismar K: Fibroblasts derivedfrom human chronic diabetic wounds have a decreased proliferation rate, which is recovered by the addition of heparin. J Dermatol Sci 1998;2:144-151. 26. Hehenberger K, Hansson A. High glucose in the use growth factor resistance in human fibroblast can be reversed by antioxidants and protein kinase C-inhibitors. Cell Biochem 1997;3:197-201. 27. Hehenberger K, Heilborn JD, Brismar K, Hansson A. Inhibited proliferation of fibroblasts derived from chronic diabetic wounds and normal dermal fibroblasts treated with high 07_당뇨발궤양: 경과와 관리 47

glucose is associated with increased formation of l-lactate. Wound Repair Regen 1998;6(2):135-141. 28. Jeffcoate WJ, MacFarlane, RM, Fletcher EM. The description and classification of diabetic foot lesions. Diabetic Med 1993;10:676-679. 29. Laing P. The development and complications of diabetic foot ulcers. Am J Surg 1998;176 (suppl 2a):11-19. 30. Landau Z. Topical hyperbaric oxygen and lower energy laser for the treatment of diabetic foot ulcers. Arch Orthop Trauma Surg 1998;3:156-158. 31. Lavery LA, Armstrong DG, Vela SA, Quebedeaux TL, Fleischli JG. Practical criteria for screening patients at high risk for diabetic foot ulceration. Arch Intern Med 1998;15:157-162. 32. Leslie C, Sapico FL, Ginunas VJ, Adkins RH. Randomized controlled trial of topical hyperbaric oxygen for treatment of diabetic foot ulcers. Diabetes Care 1988;11(2):111-115. 33. LoGerfo FW, Gibbons GW, Pomposelli FB Jr, et al. Trends in the care of the diabetic foot. Expanded role of arterialreconstruction. Arch Surg 1992;127(5):617-620. 34. Mayfield JA, Reiber GE, Nelson RG, Greene T. A foot risk classification system to predict diabetes amputations in Pima Indians. Diabetes Care 1996;19(7):704-709. 35. Macfarlane RM, Jeffcoate WJ. Factors contributing to the presentationof diabetic foot ulcers. Diabetic Med 1997;14:867-870. 36. Morris AD, McAlpine R, Steinke D. Diabetes and lower limb amputations in the community. A retrospective cohort study. Diabetes Care 1998;5:738-743. 37. Naughton G, Mansbridge J, Gentzkow G. A metabolically active human dermal replacement for the treatment of diabetic footulcers. Artif Organs 1997;21:1203-1210. 38. Nwomeh BC, Yager DR, Cohen IK. Physiology of the chronic wound. Clin Plast Surg 1998;25(3)341-356. 39. Piaggesi A, Schipani E, Campi F, et al. Conservative surgical approach versus non-surgical management for diabetic neuropathic foot ulcer: A randomized trial. Diabetic Med 1998;5:412-417. 40. Pham HT, Economides PA, Veves A. The role of endothelial function on the foot: microcirculation and wound healing in patients with diabetes. Clin Podiatr Med Surg 1998;15:85-94. 41. Reiber GE, Pecoraro RE, Koepsell TD. Risk factors for amputations in patients with diabetes mellitus. A case-control study. Ann Int Med 1992;117(2):97-105. 42. Richard J, Parer-Richard C, Davies JP, et al. Effect of topical basic fibroblast growth 48 당뇨발병변 진료지침

glucose is associated with increased formation of l-lactate. Wound Repair Regen<br />

1998;6(2):135-141.<br />

28. Jeffcoate WJ, MacFarlane, RM, Fletcher EM. The description and classification of diabetic<br />

foot lesions. Diabetic Med 1993;10:676-679.<br />

29. Laing P. The development and complications of diabetic foot ulcers. Am J Surg 1998;176<br />

(suppl 2a):11-19.<br />

30. Landau Z. Topical hyperbaric oxygen and lower energy laser for the treatment of diabetic<br />

foot ulcers. Arch Orthop Trauma Surg 1998;3:156-158.<br />

31. Lavery LA, Armstrong DG, Vela SA, Quebedeaux TL, Fleischli JG. Practical criteria for<br />

screening patients at high risk for diabetic foot ulceration. Arch Intern Med<br />

1998;15:157-162.<br />

32. Leslie C, Sapico FL, Ginunas VJ, Adkins RH. Randomized controlled trial of topical<br />

hyperbaric oxygen for treatment of diabetic foot ulcers. Diabetes Care 1988;11(2):111-115.<br />

33. LoGerfo FW, Gibbons GW, Pomposelli FB Jr, et al. Trends in the care of the diabetic<br />

foot. Expanded role of arterialreconstruction. Arch Surg 1992;127(5):617-620.<br />

34. Mayfield JA, Reiber GE, Nelson RG, Greene T. A foot risk classification system to<br />

predict diabetes amputations in Pima Indians. Diabetes Care 1996;19(7):704-709.<br />

35. Macfarlane RM, Jeffcoate WJ. Factors contributing to the presentationof diabetic foot<br />

ulcers. Diabetic Med 1997;14:867-870.<br />

36. Morris AD, McAlpine R, Steinke D. Diabetes and lower limb amputations in the<br />

community. A retrospective cohort study. Diabetes Care 1998;5:738-743.<br />

37. Naughton G, Mansbridge J, Gentzkow G. A metabolically active human dermal<br />

replacement for the treatment of diabetic footulcers. Artif Organs 1997;21:1203-1210.<br />

38. Nwomeh BC, Yager DR, Cohen IK. Physiology of the chronic wound. Clin Plast Surg<br />

1998;25(3)341-356.<br />

39. Piaggesi A, Schipani E, Campi F, et al. Conservative surgical approach versus non-surgical<br />

management for diabetic neuropathic foot ulcer: A randomized trial. Diabetic Med<br />

1998;5:412-417.<br />

40. Pham HT, Economides PA, Veves A. The role of endothelial function on the foot:<br />

microcirculation and wound healing in patients with diabetes. Clin Podiatr Med Surg<br />

1998;15:85-94.<br />

41. Reiber GE, Pecoraro RE, Koepsell TD. Risk factors for amputations in patients with<br />

diabetes mellitus. A case-control study. Ann Int Med 1992;117(2):97-105.<br />

42. Richard J, Parer-Richard C, Davies JP, et al. Effect of topical basic fibroblast growth<br />

48 <strong>당뇨발병변</strong> <strong>진료지침</strong>

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!